Delcath Systems 's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Delcath Systems, Inc. (DCTH)

Q2 2012 Earnings Call

August 7, 2012 8:30 am ET

Executives

Doug Sherk – Investor Relations, EVC Group

Eamonn Hobbs – Chief Executive Officer, President and Director

Graham Miao – Executive Vice President and Chief Financial Officer

Analysts

Matthew Dolan – ROTH Capital Partners

Jason Mills – Canaccord Genuity

Presentation

Operator

Good day ladies and gentlemen. Thank you for standing by. Welcome to the Delcath second quarter 2012 corporate update conference call. During today’s presentation, all parties will be in a listen-only mode. Following the presentation the conference will be open for questions. (Operator instructions)

This conference is being recorded today, August 7, 2012. I would now like to turn the conference over to Doug Sherk. Please go ahead sir.

Doug Sherk

Thank you operator, and good morning everyone. Thank you for joining us today for this conference call and web cast to provide an update on Delcath’s second quarter 2012 results and recent corporate progress.

A replay of the conference call will be made available beginning approximately 2 hours after the conclusion of today’s call, and it will be available for seven days. The operator will provide replay details at the conclusion of today’s call. A live webcast of this call is available at www.delcath.com and the call will also be archived on the website.

Before we begin, I would like to remind you that some of the statements made during this conference call will contain forward-looking statements within the meaning of the Safe Harbor Provision of the US Private Securities Litigation Reform Act of 1995. These statements are subject to certain risks and uncertainties and actual results could differ materially from those projected in any forward-looking statements.

If you liked this article you might like

3 Breakout Stocks Under $10 to Trade Now

Delcath Systems (DCTH) Weak On High Volume

5 Active Under-$10 Stocks to Buy Now

Northwest Bio's German Smokescreen Obscures DCVax Problems

4 Stocks Under $10 Making Big Moves